MeSH D055623 - actinic keratosis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Padagis | Imiquimod | Imiquimod | 2010-09-07 | |||
| Ingenol mebutate | Ingenol Mebutate | 2019-01-07 | ||||
| Taro Pharmaceutical | Imiquimod | Imiquimod | 2011-04-15 | |||
| Glenmark Pharmaceuticals | Imiquimod | Imiquimod | 2012-03-06 | |||
| LEO Pharma | Ingenol mebutate | Picato | 2026-12-18 | 2012-01-23 | ||
| Almirall | Tirbanibulin | Klisyri | 2021-07-16 | |||
| 3M | Imiquimod | Zartra | 1998-09-18 | |||
| Bausch Health Companies | Imiquimod | Aldara | 2024-04-01 | 1997-02-27 | ||
| Imiquimod | Zyclara | 2029-08-18 | 2010-03-25 | |||
| Cosette Pharmaceuticals | Imiquimod | Imiquimod | 2011-04-18 | |||
| Apotex | Imiquimod | Imiquimod | 2012-04-06 | |||
| Strides Pharma Global | Imiquimod | Imiquimod | 2014-06-24 |
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
83%15/18
Phase 2
30%7/23
Phase 3
83%15/18
Approved: 7Overall Success rate: 21%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use